Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Krista-Liisa Vidqvist"'
Autor:
Tea Lamberg, Taina Sipponen, Sanna Valtanen, Kari K Eklund, Tarja Mälkönen, Kristiina Aalto, Katriina Mikola, Kaija-Leena Kolho, Sanna Leinonen, Pia Isomäki, Heidi Mäkinen, Krista-Liisa Vidqvist, Arto Kokko, Laura Huilaja, Minna Kyllönen, Paula Keskitalo, Sirja Sard, Paula Vähäsalo, Ritva Koskela, Liisa Kröger, Perttu Lahtinen, Anna-Maija Haapala, Katja Korkatti, Tuulikki Sokka-Isler, T. Sakari Jokiranta
Publikováno v:
Autoimmunity, Vol 55, Iss 5, Pp 275-284 (2022)
Introduction The prevalence of immune-mediated diseases has increased in the past decades and despite the use of biological treatments all patients do not achieve remission. The aim of this study was to characterise the reasons for short interruption
Externí odkaz:
https://doaj.org/article/d471061e9b8a414b9021f87dde85a9bf
Autor:
Atte Valli, Krista Kuuliala, Anniina Virtanen, Antti Kuuliala, Maaria Palmroth, Ritva Peltomaa, Krista-Liisa Vidqvist, Marjatta Leirisalo-Repo, Olli Silvennoinen, Pia Isomäki
Sixteen patients with active rheumatoid arthritis, despite conventional synthetic disease-modifying antirheumatic drugs, started additional tofacitinib treatment. Blood samples were drawn at baseline and at 3-month follow-up visits, and plasma levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b3574dae24bc32e18f6d1d8399f4c0f
https://trepo.tuni.fi/handle/10024/145112
https://trepo.tuni.fi/handle/10024/145112
Publikováno v:
Rheumatology. 54:1103-1113
Objective Many cytokines involved in RA activate the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathways. Therapeutic drugs that inhibit these pathways are being developed for RA. To investigate disease-related alteratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0170e6e764c89c02e7cb1be5d115c82b
https://doi.org/10.1093/rheumatology/keu430
https://doi.org/10.1093/rheumatology/keu430
Publikováno v:
Rheumatology. 52:1999-2003
Objectives To investigate the use of DMARDs and biologic treatments and disease activity in patients with JIA referred to the adult rheumatology clinic and to provide further information regarding the need for long-term rheumatologic care. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7ec1ca72ffabb535aa63eb31070f0b
https://doi.org/10.1093/rheumatology/ket256
https://doi.org/10.1093/rheumatology/ket256
Publikováno v:
Rheumatology; Jun2015, Vol. 54 Issue 6, p1103-1113, 11p, 1 Chart, 5 Graphs